Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mereo BioPharma Group plc - American Depositary Shares (NQ:MREO)

2.740 +0.280 (+11.38%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,194,059
Open 2.500
Bid (Size) 2.690 (5)
Ask (Size) 2.780 (25)
Prev. Close 2.460
Today's Range 2.490 - 2.780
52wk Range 1.575 - 5.020
Shares Outstanding 584,908,239
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Rio Tinto, Bumble And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Why Credo Technology Group Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Performance

YTD
-19.9%
-19.9%
1 Month
+17.6%
+17.6%
3 Month
+9.2%
+9.2%
6 Month
-21.0%
-21.0%
1 Year
-21.7%
-21.7%

More News

Read More
Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights
From Mereo BioPharma Group plc
Via GlobeNewswire
This Roper Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights
From Mereo BioPharma Group plc
Via GlobeNewswire
Hidden Gems: 5 Stocks Under $10 With Massive Growth Potential
Via MarketBeat
Topics Electric Vehicles
Exposures Electric Vehicles
Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference
From Mereo BioPharma Group plc
Via GlobeNewswire
Mereo BioPharma Provides Update on Lead Clinical Programs
From Mereo BioPharma Group plc
Via GlobeNewswire
Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Mereo BioPharma Group plc
Via GlobeNewswire
This ServiceNow Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
Via Benzinga
Crude Oil Down 1%; Webuy Global Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
This Constellation Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference
From Mereo BioPharma Group plc
Via GlobeNewswire
Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
From Mereo BioPharma Group plc
Via GlobeNewswire
Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference
From Mereo BioPharma Group plc
Via GlobeNewswire
Liquidia, Shake Shack And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
From Mereo BioPharma Group plc
Via GlobeNewswire
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market
From Mereo BioPharma Group plc
Via GlobeNewswire
Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Uber To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Why Oracle Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI)
From Ultragenyx Pharmaceutical Inc.
Via GlobeNewswire
Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference
From Mereo BioPharma Group plc
Via GlobeNewswire
Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
From Mereo BioPharma Group plc
Via GlobeNewswire

Frequently Asked Questions

Is Mereo BioPharma Group plc - American Depositary Shares publicly traded?
Yes, Mereo BioPharma Group plc - American Depositary Shares is publicly traded.
What exchange does Mereo BioPharma Group plc - American Depositary Shares trade on?
Mereo BioPharma Group plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Mereo BioPharma Group plc - American Depositary Shares?
The ticker symbol for Mereo BioPharma Group plc - American Depositary Shares is MREO on the Nasdaq Stock Market
What is the current price of Mereo BioPharma Group plc - American Depositary Shares?
The current price of Mereo BioPharma Group plc - American Depositary Shares is 2.740
When was Mereo BioPharma Group plc - American Depositary Shares last traded?
The last trade of Mereo BioPharma Group plc - American Depositary Shares was at 06/06/25 04:00 PM ET
What is the market capitalization of Mereo BioPharma Group plc - American Depositary Shares?
The market capitalization of Mereo BioPharma Group plc - American Depositary Shares is 1.60B
How many shares of Mereo BioPharma Group plc - American Depositary Shares are outstanding?
Mereo BioPharma Group plc - American Depositary Shares has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.